GPCR-mediated natural products and compounds: Potential therapeutic targets for the treatment of neurological diseases

被引:0
作者
Wang, Xing Xia [1 ,2 ]
Ji, Xiang [1 ]
Lin, Jing [3 ]
Wong, Io Nam [5 ]
Lo, Hang Hong [1 ]
Wang, Jian [4 ]
Qu, Liqun [1 ]
Wong, Vincent Kam Wai [1 ]
Chung, Sookja Kim [1 ,5 ]
Law, Betty Yuen Kwan [1 ]
机构
[1] Macau Univ Sci & Technol, Nehers Biophys Lab Innovat Drug Discovery, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Sichuan, Peoples R China
[3] Luzhou Hosp Tradit Chinese Med, Dept Endocrinol, Luzhou, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp, Sichuan Clin Res Ctr Canc,Sichuan Canc Ctr,Dept Me, Chengdu, Peoples R China
[5] Macau Univ Sci & Technol, Fac Med, Macau, Peoples R China
关键词
Natural products; G protein-coupled receptors; Central nervous system; Neurological disorders; PROTEIN-COUPLED RECEPTORS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; JITAI TABLETS; DOUBLE-BLIND; RAT MODEL; IN-VITRO; DOPAMINE; PHARMACOLOGY;
D O I
10.1016/j.phrs.2024.107395
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs), widely expressed in the human central nervous system (CNS), perform numerous physiological functions and play a significant role in the pathogenesis of diseases. Consequently, identifying key therapeutic GPCRs targets for CNS-related diseases is garnering immense interest in research labs and pharmaceutical companies. However, using GPCRs drugs for treating neurodegenerative diseases has limitations, including side effects and uncertain effective time frame. Recognizing the rich history of herbal treatments for neurological disorders like stroke, Alzheimer's disease (AD), and Parkinson's disease (PD), modern pharmacological research is now focusing on the understanding of the efficacy of traditional Chinese medicinal herbs and compounds in modulating GPCRs and treatment of neurodegenerative conditions. This paper will offer a comprehensive, critical review of how certain natural products and compounds target GPCRs to treat neurological diseases. Conducting an in-depth study of herbal remedies and their efficacies against CNS-related disorders through GPCRs targeting will augment our strategies for treating neurological disorders. This will not only broaden our understanding of effective therapeutic methodologies but also identify the root causes of altered GPCRs signaling in the context of pathophysiological mechanisms in neurological diseases. Moreover, it would be informative for the creation of safer and more effective GPCR-mediated drugs, thereby establishing a foundation for future treatment of various neurological diseases.
引用
收藏
页数:12
相关论文
共 179 条
  • [1] Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective
    Ahmed, Alveena
    Boulton, Stephen
    Shao, Hongzhao
    Akimoto, Madoka
    Natarajan, Amarnath
    Cheng, Xiaodong
    Melacini, Giuseppe
    [J]. CELLS, 2019, 8 (11)
  • [2] The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases
    Argenziano, Maura
    Tortora, Chiara
    Bellini, Giulia
    Di Paola, Alessandra
    Punzo, Francesca
    Rossi, Francesca
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [3] G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
    Azam, Shofiul
    Haque, Md. Ezazul
    Jakaria, Md.
    Jo, Song-Hee
    Kim, In-Su
    Choi, Dong-Kug
    [J]. CELLS, 2020, 9 (02)
  • [4] Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante, Flavio
    Kooistra, Albert J.
    Kampen, Stefanie
    de Graaf, Chris
    Carlsson, Jens
    [J]. PHARMACOLOGICAL REVIEWS, 2021, 73 (04) : 527 - 565
  • [5] RETRACTED: Triptolide Attenuates Neuropathic Pain by Regulating Microglia Polarization through the CCL2/CCR2 Axis (Retracted Article)
    Bao, Xubin
    Chen, Cai
    Yuan, Liyong
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [6] The Physiology, Signaling, and Pharmacology of Dopamine Receptors
    Beaulieu, Jean-Martin
    Gainetdinov, Raul R.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 182 - 217
  • [7] L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain
    Bezard, E
    Gross, CE
    Qin, L
    Gurevich, VV
    Benovic, JL
    Gurevich, EV
    [J]. NEUROBIOLOGY OF DISEASE, 2005, 18 (02) : 323 - 335
  • [8] Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery
    Bietar, Bashir
    Tanner, Sophie
    Lehmann, Christian
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [9] TNFα promotes mucosal wound repair through enhanced platelet activating factor receptor signaling in the epithelium
    Birkl, Dorothee
    Quiros, Miguel
    Garcia-Hernandez, Vicky
    Zhou, Dennis W.
    Brazil, Jennifer C.
    Hilgarth, Roland
    Keeney, Justin
    Yulis, Mark
    Bruewer, Matthias
    Garcia, Andres J.
    O'Leary, Monique N.
    Parkos, Charles A.
    Nusrat, Asma
    [J]. MUCOSAL IMMUNOLOGY, 2019, 12 (04) : 909 - 918
  • [10] Cholinesterase inhibitors for Alzheimer's disease
    Birks, J
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):